ADMA — ADMA BIOLOGICS, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ADMA
| date | signal | measured base rate |
|---|---|---|
| 2026-08-14 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-08-11 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-08-06 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-23 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-10 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-06-10 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-24 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for tax | 3.2K | 8.37 | 26.6K |
| 2026-07-16 | Kohler Terry CFO and Treasurer | Grant or award | 85.1K | 0.00 | 0 |
| 2026-05-27 | Grossman Jerrold B Director | Open-market purchase | 6.4K | 7.91 | 50.6K |
| 2026-05-12 | Grossman Jerrold B Director | Open-market purchase | 12.5K | 8.01 | 100.1K |
| 2026-05-11 | Grossman Jerrold B Director | Open-market purchase | 12.5K | 8.01 | 100.1K |
| 2026-04-01 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for tax | 20.4K | 9.11 | 185.5K |
| 2026-03-17 | Guiheen Lawrence P. Director | Gift | 30.0K | 0.00 | 0 |
| 2026-03-17 | Guiheen Lawrence P. Director | Gift | 30.0K | 0.00 | 0 |
| 2026-03-16 | Grossman Adam S President and CEO | Open-market sale 10b5-1 plan | 15.0K | 15.16 | 227.4K |
| 2026-03-16 | Grossman Adam S President and CEO | Open-market sale 10b5-1 plan | 6.0K | 15.16 | 91.0K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 331.8M | 36.8M |
| STATE STREET CORP | 126.9M | 14.1M |
| Capital Research Global Investors | 100.8M | 11.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 92.9M | 10.3M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 79.9M | 8.9M |
| Nuveen, LLC | 54.9M | 6.1M |
| GEODE CAPITAL MANAGEMENT, LLC | 52.5M | 5.8M |
| CITADEL ADVISORS LLC | 52.4M | 5.8M |
| DIMENSIONAL FUND ADVISORS LP | 45.1M | 5.0M |
| AMERICAN CENTURY COMPANIES INC | 43.1M | 4.8M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law · 2026-08-21
- ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA · 2026-08-21
- Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA) · 2026-08-17
- Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA) · 2026-08-17
- ADMA Biologics, Inc. Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm · 2026-08-10
Ask the AI about ADMA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →